Literature DB >> 8436241

Interconnection of integrins alpha 2 and alpha 3 and structure of the basal membrane in colorectal cancer: relation to survival.

G Lindmark1, B Gerdin, L Påhlman, B Glimelius, K Gehlsen, K Rubin.   

Abstract

The expression and distribution of integrin subunits alpha 2 and alpha 3 and two of their putative ligands, type IV collagen and laminin, were examined by immunohistochemistry in specimens from 33 consecutive patients operated on for colorectal adenocarcinomas. Both tumour cells and normal epithelium expressed the alpha 2 and alpha 3 subunits. Two typical patterns of expression could be discerned; a basolateral expression and a diffuse cytoplasmic expression. The stained tumour specimens were assessed according to (i) distribution of integrin expression (diffusely cytoplasmic or basolateral), (ii) continuity in basolateral integrin expression, and (iii) interconnection of integrin expression and expression of type IV collagen and laminin. These parameters were then related to tumour differentiation, tumour stage according to Dukes' classification, DNA-ploidy and patient survival (median observation time was 30 months; range 24-35). The continuity in the basolateral expression of alpha 3 but not of alpha 2, correlated with the basal membrane expression of type IV collagen (P < 0.001). Loss of continuity in the basolateral expression of both integrins was significantly related to impaired tumour differentiation (alpha 2 P = 0.02; alpha 3 P = 0.01), more advanced Dukes' stage (alpha 2 = 0.07, alpha 3 P < 0.001), survival rate (both integrins P < 0.05), but not to DNA-ploidy. These data suggest that determination of the pattern of expression of the integrin subunits alpha 2 and alpha 3 in the preoperative biopsy and the surgical specimen could be used as a prognostic indicator.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8436241

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  10 in total

1.  Beta1-integrin-mediated dynamic adhesion of colon carcinoma cells to extracellular matrix under laminar flow.

Authors:  J Haier; M Y Nasralla; G L Nicolson
Journal:  Clin Exp Metastasis       Date:  1999-07       Impact factor: 5.150

Review 2.  Cell surface molecules and their prognostic values in assessing colorectal carcinomas.

Authors:  J Haier; M Nasralla; G L Nicolson
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

3.  P-selectin activates integrin-mediated colon carcinoma cell adhesion to fibronectin.

Authors:  Merit E Reyes-Reyes; Margaret D George; John D Roberts; Steven K Akiyama
Journal:  Exp Cell Res       Date:  2006-09-16       Impact factor: 3.905

Review 4.  Altered integrin expression and the malignant phenotype: the contribution of multiple integrated integrin receptors.

Authors:  M M Zutter; H Sun; S A Santoro
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-04       Impact factor: 2.673

5.  Altered expression of extracellular matrix molecules and their receptors in chronic pancreatitis and pancreatic adenocarcinoma in comparison with normal pancreas.

Authors:  S Shimoyama; F Gansauge; S Gansauge; T Oohara; H G Beger
Journal:  Int J Pancreatol       Date:  1995-12

6.  Prognostic value of β1 integrin expression in colorectal liver metastases.

Authors:  Nikolaos Vassos; Tilman Rau; Susanne Merkel; Fabian Feiersinger; Carol I Geppert; Michael Stürzl; Werner Hohenberger; Roland S Croner
Journal:  Int J Clin Exp Pathol       Date:  2013-12-15

7.  Functional blocking of specific integrins inhibit colonic cancer migration.

Authors:  John H Robertson; Shi Yu Yang; Marc C Winslet; Alexander M Seifalian
Journal:  Clin Exp Metastasis       Date:  2009-06-26       Impact factor: 5.150

8.  Different adhesion properties of highly and poorly metastatic HT-29 colon carcinoma cells with extracellular matrix components: role of integrin expression and cytoskeletal components.

Authors:  J Haier; M Nasralla; G L Nicolson
Journal:  Br J Cancer       Date:  1999-08       Impact factor: 7.640

9.  Identification of the anticancer effects of a novel proteasome inhibitor, ixazomib, on colorectal cancer using a combined method of microarray and bioinformatics analysis.

Authors:  Qiaowei Fan; Bingrong Liu
Journal:  Onco Targets Ther       Date:  2017-07-19       Impact factor: 4.147

10.  Multiplicity of fibronectin-binding alpha V integrin receptors in colorectal cancer.

Authors:  M V Agrez; R C Bates; D Mitchell; N Wilson; N Ferguson; P Anseline; D Sheppard
Journal:  Br J Cancer       Date:  1996-04       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.